Lineage tracing of mutant granulosa cells reveals in vivo protective mechanisms that prevent granulosa cell tumorigenesis

Cell Death Differ. 2023 May;30(5):1235-1246. doi: 10.1038/s41418-023-01132-1. Epub 2023 Feb 23.

Abstract

Ovarian granulosa cell tumors (GCTs) originate from granulosa cells (GCs) and represent the most common sex cord-stromal tumor in humans. However, the developmental regulations and molecular mechanisms underlying their etiology are largely unknown. In the current study, we combined a multi-fluorescent reporter mouse model with a conditional knockout mouse model, in which the tumor suppressor genes Pten and p27 were deleted in GCs, to perform cell lineage tracing of mutant GCs. We found that only 30% of ovaries with substantial mutant GCs developed into GCTs that derived from a single mutant GC. In-depth molecular analysis of the process of tumorigenesis demonstrated that up-regulation of immune evasion genes Cd24a and Cd47 led, in part, to the transition of mutant GCs to GCTs. Therefore, treatment with the Cd47 inhibitor RRX-001 was tested and found to efficiently suppress the growth of GCTs in vivo. Together, our study has revealed an immune evasion mechanism via CD24/CD47 upregulation to GCT formation, shedding light on the future potential clinical therapies for GCTs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD47 Antigen / genetics
  • Carcinogenesis / genetics
  • Carcinogenesis / pathology
  • Cell Transformation, Neoplastic / pathology
  • Female
  • Granulosa Cell Tumor* / drug therapy
  • Granulosa Cell Tumor* / genetics
  • Granulosa Cell Tumor* / pathology
  • Granulosa Cells
  • Humans
  • Mice
  • Mice, Knockout
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / pathology

Substances

  • CD47 Antigen